ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C10AB05 | B | Fenofibrate - 160mg | 10547 | 1921/1 | LIPANTHYL | 160mg | 30 | Tablet, film coated, modified release | Oral | Mersaco | Pharmaline Licensed by Abbott Laboratories GmbH, Germany | Lebanon | 224,354 L.L | 23.08 | A2 | 2/1/2023 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C10AB05 | G | Fenofibrate - 160mg | 7727 | 186994/14 | FENOFIBRATE ARROW | 160mg | 30 | Tablet | Oral | Darapharma S.A.L. | BTT | France | 489,054 L.L | 23.08 | A1 | Arrow Génériques | France | 2/1/2023 |
C10AB05 | G | Fenofibrate - 160mg | 5856 | 218806/09 | FENOSUP LIDOSE | 160mg | 30 | Capsule | Oral | Pharmamedic S.A.R.L. | SMB Technology SA | Belgium | 435,891 L.L | 23.08 | A2 | SMB SA | Belgium | 2/1/2023 |